111, Inc. (YI)
NASDAQ: YI · IEX Real-Time Price · USD
1.195
+0.065 (5.75%)
At close: Jul 26, 2024, 3:59 PM
1.190
-0.005 (-0.42%)
After-hours: Jul 26, 2024, 4:00 PM EDT
111, Inc. Market Cap
111, Inc. has a market cap or net worth of $101.77 million as of July 26, 2024. Its market cap has decreased by -56.40% in one year.
Market Cap
101.77M
Enterprise Value
42.23M
1-Year Change
-56.40%
Ranking
Category
Stock Price
$1.20
Market Cap Chart
Since September 12, 2018, 111, Inc.'s market cap has decreased from $1.14B to $101.77M, a decrease of -91.10%. That is a compound annual growth rate of -33.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 25, 2024 | 96.60M | -26.26% |
| Dec 29, 2023 | 131.00M | -47.95% |
| Dec 30, 2022 | 251.70M | -13.33% |
| Dec 31, 2021 | 290.40M | -49.08% |
| Dec 31, 2020 | 570.30M | 3.92% |
| Dec 31, 2019 | 548.80M | 7.86% |
| Dec 31, 2018 | 508.80M | -55.51% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| VistaGen Therapeutics | 99.56M |
| Aclaris Therapeutics | 98.35M |
| So-Young International | 96.15M |
| Sagimet Biosciences | 96.04M |
| Xtant Medical Holdings | 94.46M |
| Checkpoint Therapeutics | 92.89M |
| Eupraxia Pharmaceuticals | 92.26M |
| Asensus Surgical | 92.17M |